The Role of Measurement in Action and Accountability
INSTITUTE OF MEDICINE
OF THE NATIONAL ACADEMIES
THE NATIONAL ACADEMIES PRESS
Washington, D.C.
www.nap.edu
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page R1
Committee on Public Health Strategies to Improve Health
Board on Population Health and Public Health Practice
OCR for page R1
THE NATIONAL ACADEMIES PRESS 500 Fifth Street, N.W. Washington, DC 20001
NOTICE: The project that is the subject of this report was approved by the Governing Board
of the National Research Council, whose members are drawn from the councils of the National
Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The
members of the committee responsible for the report were chosen for their special competences
and with regard for appropriate balance.
This study was supported by Contract No. 65863 between the National Academy of Sciences
and the Robert Wood Johnson Foundation. Any opinions, findings, conclusions, or recommen-
dations expressed in this publication are those of the author(s) and do not necessarily reflect
the view of the organizations or agencies that provided support for this project.
Library of Congress Cataloging-in-Publication Data
For the public’s health : the role of measurement in action and accountability / Committee
on Public Health Strategies to Improve Health, Board on Population Health and Public
Health Practice, Institute of Medicine.
p. ; cm.
Includes bibliographical references and index.
ISBN 978-0-309-16127-5 (hardcover : alk. paper) — ISBN 978-0-309-16128-2 (pdf : alk.
paper) 1. Public health administration—United States. 2. Health status indicators—United
States. I. Institute of Medicine (U.S.). Committee on Public Health Strategies to Improve
Health.
[DNLM: 1. Public Health Administration—standards—United States. 2. Health Status
Indicators—United States. 3. Social Responsibility—United States. WA 540 AA1]
RA445.F657 2011
362.1—dc22
2011004593
Additional copies of this report are available from the National Academies Press, 500 Fifth
Street, N.W., Lockbox 285, Washington, DC 20055; (800) 624-6242 or (202) 334-3313 (in
the Washington metropolitan area); Internet, http://www.nap.edu.
For more information about the Institute of Medicine, visit the IOM home page at: www.
iom.edu.
Copyright 2011 by the National Academy of Sciences. All rights reserved.
Printed in the United States of America
The serpent has been a symbol of long life, healing, and knowledge among almost all cultures
and religions since the beginning of recorded history. The serpent adopted as a logotype by
the Institute of Medicine is a relief carving from ancient Greece, now held by the Staatliche
Museen in Berlin.
Suggested citation: IOM (Institute of Medicine). 2011. For the Public’s Health: The Role of
Measurement in Action and Accountability. Washington, DC: The National Academies Press.
OCR for page R1
“Knowing is not enough; we must apply.
Willing is not enough; we must do.”
— Goethe
Advising the Nation. Improving Health.
OCR for page R1
The National Academy of Sciences is a private, nonprofit, self-perpetuating society of
distinguished scholars engaged in scientific and engineering research, dedicated to the
furtherance of science and technology and to their use for the general welfare. Upon
the authority of the charter granted to it by the Congress in 1863, the Academy has
a mandate that requires it to advise the federal government on scientific and techni-
cal matters. Dr. Ralph J. Cicerone is president of the National Academy of Sciences.
The National Academy of Engineering was established in 1964, under the charter
of the National Academy of Sciences, as a parallel organization of outstanding en-
gineers. It is autonomous in its administration and in the selection of its members,
sharing with the National Academy of Sciences the responsibility for advising the
federal government. The National Academy of Engineering also sponsors engineer-
ing programs aimed at meeting national needs, encourages education and research,
and recognizes the superior achievements of engineers. Dr. Charles M. Vest is presi-
dent of the National Academy of Engineering.
The Institute of Medicine was established in 1970 by the National Academy of
Sciences to secure the services of eminent members of appropriate professions in
the examination of policy matters pertaining to the health of the public. The Insti-
tute acts under the responsibility given to the National Academy of Sciences by its
congressional charter to be an adviser to the federal government and, upon its own
initiative, to identify issues of medical care, research, and education. Dr. Harvey V.
Fineberg is president of the Institute of Medicine.
The National Research Council was organized by the National Academy of Sci-
ences in 1916 to associate the broad community of science and technology with the
Academy’s purposes of furthering knowledge and advising the federal government.
Functioning in accordance with general policies determined by the Academy, the
Council has become the principal operating agency of both the National Academy
of Sciences and the National Academy of Engineering in providing services to the
government, the public, and the scientific and engineering communities. The Council
is administered jointly by both Academies and the Institute of Medicine. Dr. Ralph
J. Cicerone and Dr. Charles M. Vest are chair and vice chair, respectively, of the
National Research Council.
www.national-academies.org
OCR for page R1
COMMITTEE ON PUBLIC HEALTH
STRATEGIES TO IMPROVE HEALTH
MARTHE R. GOLD (Chair), Professor and Chair, Department of
Community Health and Social Medicine, Sophie Davis School of
Biomedical Education, City College, New York, NY
STEVEN M. TEUTSCH (Vice Chair), Chief Science Officer, Los Angeles
County Department of Public Health, Los Angeles, CA
LESLIE BEITSCH, Associate Dean for Health Affairs; Director, Center
on Medicine and Public Health, Florida State University College of
Medicine, Tallahassee, FL
JOYCE D. K. ESSIEN, Director, Center for Public Health Practice, Rollins
School of Public Health, Emory University; Senior Medical Advisor,
Research and Outcomes Branch, Division of Public Health Performance
Improvement, Office for State, Tribal, Local and Territorial Support,
National Centers for Disease Control and Prevention, Atlanta, GA
DAVID W. FLEMING, Director and Health Officer for Public Health,
Seattle & King County, Seattle, WA
THOMAS E. GETZEN, Professor of Risk, Insurance and Health
Management, Fox School of Business, Temple University; Executive
Director, International Health Economics Association (iHEA)
Philadelphia, PA
LAWRENCE O. GOSTIN, Linda and Timothy O’Neill Professor of Global
Health Law and the Director of the O’Neill Institute for National and
Global Health Law at Georgetown University, Washington, DC
MARY MINCER HANSEN, Director of the Masters of Public Health
Program; Adjunct Associate Professor, Department of Global Health,
Des Moines University, IA
GEORGE J. ISHAM, Medical Director and Chief Health Officer,
HealthPartners, Bloomington, MN
ROBERT M. KAPLAN, Distinguished Professor of Health Services,
Distinguished Professor of Medicine, David Geffen School of Medicine,
University of California, Los Angeles, CA
WILFREDO LOPEZ, General Counsel Emeritus, New York City
Department of Health and Mental Hygiene, NY
GLEN P. MAYS, Professor and Chairman, Department of Health Policy
and Management, Fay W. Boozman College of Public Health, University
of Arkansas Medical Sciences, Little Rock, AR
PHYLLIS D. MEADOWS, Associate Dean for Practice, Office of Public
Health Practice; Clinical Professor, Department of Health Management
and Policy, University of Michigan, School of Public Health, Ann
Arbor, MI
POKI STEWART NAMKUNG, Health Officer, Santa Cruz County Health
Services Agency, Santa Cruz, CA
v
OCR for page R1
MARGARET E. O’KANE, President, National Committee for Quality
Assurance, Washington, DC
DAVID A. ROSS, Director, Public Health Informatics Institute, The Task
Force for Global Health, Decatur, GA
MARTÍN JOSÉ SEPÚLVEDA, IBM Fellow and Vice President,
International Business Machines Corporation, Somers, NY
STEVEN H. WOOLF, Professor, Departments of Family Medicine,
Epidemiology, and Community Health, Virginia Commonwealth
University, Richmond, VA
Study Staff
ALINA B. BACIU, Study Director
AMY GELLER, Program Officer
ALEJANDRA MARTÍN, Research Assistant
RAINA SHARMA, Senior Program Assistant (through July 2010)
ALLISON BERGER, Senior Program Assistant (from June 2010)
NORMAN GROSSBLATT, Senior Editor
ROSE MARIE MARTINEZ, Board Director, Board on Population Health
and Public Health Practice
vi
OCR for page R1
Reviewers
This report has been reviewed in draft form by individuals chosen
for their diverse perspectives and technical expertise, in accordance with
procedures approved by the National Research Council’s Report Review
Committee. The purpose of this independent review is to provide candid
and critical comments that will assist the institution in making its published
report as sound as possible and to ensure that the report meets institutional
standards for objectivity, evidence, and responsiveness to the study charge.
The review comments and draft manuscript remain confidential to protect
the integrity of the deliberative process. We wish to thank the following
individuals for their review of this report:
Edward Baker, University of North Carolina at Chapel Hill
Leah Devlin, University of North Carolina at Chapel Hill
Paul Erwin, University of Tennessee
Russ Glasgow, National Institutes of Health
Ron Z. Goetzel, Emory University
Anthony Iton, The California Endowment
Kenneth W. Kizer, Kizer & Associates, LLC
Paula M. Lantz, University of Michigan
Elizabeth A. McGlynn, The RAND Corporation
David Meltzer, University of Chicago
Margaret Potter, University of Pittsburgh
Mary Selecky, Washington State Department of Health
Burton H. Singer, University of Florida
Edward H. Wagner, Group Health Research Institute
vii
OCR for page R1
viii REVIEWERS
Although the reviewers listed above have provided many constructive
comments and suggestions, they were not asked to endorse the conclusions
or recommendations nor did they see the final draft of the report before
its release. The review of this report was overseen by Lawrence D. Brown,
University of Pennsylvania, and Jo Ivey Boufford, New York University.
Appointed by the National Research Council and the Institute of Medicine,
they were responsible for making certain that an independent examination
of this report was carried out in accordance with institutional procedures
and that all review comments were carefully considered. Responsibility for
the final content of this report rests entirely with the authoring committee
and the institution.
OCR for page R1
Acknowledgments
The committee wishes to thank colleagues both outside and inside the
National Academies who provided valuable information at various points in
the study process. These include Connie Citro (National Research Council
[NRC]), Gooloo Wunderlich (NRC), Michael Wolfson (University of Ot-
tawa, formerly, Statistics Canada), and Jennifer Madans (National Center
for Health Statistics, Centers for Disease Control and Prevention).
The committee learned a great deal about measurement of health from
representatives of federal, state, and local public health agencies and from
researchers and many types of practitioners who presented at the com-
mittee’s information-gathering meetings pertaining to the present report.
The meeting agendas provided in Appendix C include the names of all the
speakers.
Additional support with one technical area of the report was pro-
vided by IBM Research Division colleagues of committee member Martín
Sepúlveda. The committee thanks Peter Haas, Paul Maglio, and Pat Selinger
for their assistance with report discussions about modeling.
Finally, the committee would also like to thank the Institute of Medicine
staff members who contributed to the production of this report, includ-
ing study staff Alina Baciu, Amy Geller, Alejandra Martín, Raina Sharma,
Allison Berger, Rose Marie Martinez, and Hope Hare, as well as other staff
on the Board on Population Health who provided occasional support. The
project received valuable help from Norman Grossblatt (senior editor),
Christine Stencel (Office of News and Public Information), Christie Bell and
Amy Przybocki (Office of Financial Administration), and Greta Gorman and
colleagues (IOM Office of Review and Communication).
ix
OCR for page R1
OCR for page R1
Contents
Preface: Introduction to the Series of Reports xiii
Summary 1
1 Introduction 13
Charge to the Committee, 17
Key Terms, 19
Two Paradigms, 21
Meeting the Charge, 27
What This Report Does Not Address, 28
References, 29
2 Needed: An Information Enterprise to Drive Knowledge and
Population Health Improvement 35
The Need for a Determinants-of-Health Perspective, 38
Responsiveness to the Needs of End Users, 43
Need for Improved Coordination at the National Level
(Including Federal Agencies), 49
Concluding Observations, 59
References, 61
3 Measuring Health for Improved Decisions and Performance 67
Improving Coordination at the National Level, 67
Adopting the Determinants of Health Perspective at a
Fundamental Level, 87
xi
OCR for page R1
xii CONTENTS
Responsiveness to the Needs of End Users, 90
Concluding Observations, 103
References, 104
4 Measurement and Accountability 111
A Framework for Accountability, 113
Context and History, 121
Roles of System Stakeholders in Measuring Accountability, 123
Measurement and Accountability in the Future, 132
Types and Examples of Needed Accountability Measures, 134
Concluding Observations, 140
References, 141
APPENDIXES
A Acronyms 145
B National and Community Health Data Sets 147
C Meeting Agendas Held by the Committee on Public Health
Strategies to Improve Health (November 2009–May 2010) 171
D Committee Biosketches 179
OCR for page R1
Preface:
Introduction to the Series of Reports
In 2009, the Robert Wood Johnson Foundation asked the Institute of
Medicine (IOM) to convene a committee to examine three topics in rela-
tion to public health: measurement, the law, and funding. The committee’s
complete three-part charge is provided in Box P-1. The IOM Committee
on Public Health Strategies to Improve Health explored the topics in the
context of contemporary opportunities and challenges and with the pros-
pect of influencing the work of the health system (broadly defined as in the
report summary) in the second decade of the 21st century and beyond. The
committee was asked to prepare three reports—one on each topic—that
contained actionable recommendations for public health agencies and other
stakeholders that have roles in the health of the US population. This report
is the first in the series.
The committee’s three tasks and the series of reports prepared to re-
spond to them are linked by the recognition that measurement, laws, and
funding are three major drivers of change in the health system. Measurement
(with the data that support it) helps specialists and the public to understand
health status in different ways (for example, by determinant or underlying
cause where national, local, and comparative evidence is available), to un-
derstand the performance of the various stakeholders in the system, and to
understand the health-related results of investment. Measurement also helps
communities to understand their current status, to determine whether they
are making progress in improving health, and to set priorities for their next
actions. Although the causal chains between actions of the health system
and health outcomes are not always clearly elucidated, measurement is a
fundamental requirement for the reasons listed above.
xiii
OCR for page R1
xiv PREFACE
BOX P-1
Charge to the Committee
Task 1 (accomplished in this report)
The committee will review population health strategies, associated metrics, and
interventions in the context of a reformed health care system. The committee
will review the role of score cards and other measures or assessments in sum-
marizing the impact of the public health system, and how these can be used by
policy-makers and the community to hold both government and other stakehold-
ers accountable and to inform advocacy for public health policies and practices.
Task 2 (to be addressed in a forthcoming report)
The committee will review how statutes and regulations prevent injury and dis-
ease, save lives, and optimize health outcomes. The committee will systematically
discuss legal and regulatory authority; note past efforts to develop model public
health legislation; and describe the implications of the changing social and policy
context for public health laws and regulations.
Task 3 (to be addressed in a forthcoming report)
The committee will develop recommendations for funding state and local health
systems that support the needs of the public after health care reform. Recom-
mendations should be evidence based and implementable. In developing their
recommendations the committee will:
· Review current funding structures for public health
· Assess opportunities for use of funds to improve health outcomes
· Review the impact of fluctuations in funding for public health
· Assess innovative policies and mechanisms for funding public health ser-
vices and community-based interventions and suggest possible options
for sustainable funding.
Laws transform the underpinnings of the health system and also act
at various points in and on the complex environments that generate the
conditions for health. Those environments include the widely varied policy
context of multiple government agencies, such as education and transpor-
tation agencies, and many types of legal or legislative measure intended
to reshape the factors that improve or impede health. The measures range
from national tobacco policy to local smoking bans and from national
agricultural subsidies and school nutrition standards to local school-board
decisions about the types of foods and beverages to be sold in school vend-
ing machines.
Funding that supports the activities of public health agencies is provided
primarily by federal, state, and local governments. However, government
budgets must balance a variety of needs, programs, and policies, and the
OCR for page R1
xv
PREFACE
budgets draw on different sources (including different types of taxes and
fees), depending on jurisdiction. Therefore, the funds allocated to public
health depend heavily on how the executive and legislative branches set
priorities. Other funding sources support public health activities in the
community, including “conversion” foundations formed when nonprofit
hospitals and health insurers became privatized (such as the California
Wellness Foundation). Additionally, funds for population health and medi-
cal care activities may be provided by community-based organizations with
substantial resources, not-for-profit clinical care providers, and stakeholders
in other sectors.
The subjects addressed in the three reports are not independent of each
other and often affect one another. For example, measurement of health out-
comes and of progress in meeting objectives can provide evidence to guide
the development and implementation of public health laws and the alloca-
tion of resources for public health activities. Laws and policies often require
the collection of data and can circumscribe the uses to which the data are put
(for example, prohibiting access to personally identifiable health informa-
tion). Similarly, statutes can affect funding for public health through such
mechanisms as program-specific taxes or fees. And laws shape the structure
of public health agencies, grant them their authority, and influence policy.
In the three reports, the committee will make a case for increased ac-
countability of all sectors that affect health—including the clinical care
delivery system, the business sector, academe, nongovernment organiza-
tions, communities, and various government agencies—with coordination
by the government public health infrastructure. The present report reflects
the committee’s thinking about how accountability would look at local,
state, and national levels1 and suggests measurement strategies that would
heighten accountability and galvanize broader action by communities and
other stakeholders. In later reports, the committee will review legal and
regulatory strategies that heighten public and private responsibilities and, in
the final report, will consider resource needs and approaches to addressing
them in a sustainable manner to ensure a robust population health system.
1 The committee’s discussion about measurement framework for accountability may also
apply to territorial and tribal government, although this is not explicitly stated.
OCR for page R1